β2-Adrenergic receptors in immunity and inflammation: Stressing NF-κB

被引:101
作者
Kolmus, Krzysztof
Tavernier, Jan
Gerlo, Sarah [1 ]
机构
[1] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium
关键词
NF-kappa B; beta(2)-Adrenergic receptor; Stress; Inflammation; Immunomodulation; Signalling; NUCLEAR-FACTOR; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL INSIGHTS; PSYCHOSOCIAL STRESS; IL-6; EXPRESSION; GENE-EXPRESSION; BETA-BLOCKER; NITRIC-OXIDE; LIGAND BIAS;
D O I
10.1016/j.bbi.2014.10.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
beta(2)-Adrenergic receptors (beta(2)-ARs) transduce the effects of (nor)epinephrine on a variety of cell types and act as key mediators of the body's reaction to stress. beta(2)-ARs are also expressed on immune cells and there is ample evidence for their role in immunomodulation. A key regulator of the immune response and a target for regulation by stress-induced signals is the transcription factor Nuclear Factor-kappaB (NF-kappa B). NF-kappa B shapes the course of both innate and adaptive immune responses and plays an important role in susceptibility to disease. In this review, we summarise the literature that has been accumulated in the past 20 years on adrenergic modulation of NF-kappa B function. We here focus on the molecular basis of the reported interactions and show that both physiological and pharmacological triggers of beta(2)-ARs intersect with the NF-kappa B signalling cascade at different levels. Importantly, the action of beta(2)-AR-derived signals on NF-kappa B activity appears to be highly cell type specific and gene selective, providing opportunities for the development of selective NF-kappa B modulators. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:297 / 310
页数:14
相关论文
共 118 条
[1]   Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells -: Modulation by glucocorticoids and β-agonists [J].
Ammit, AJ ;
Lazaar, AL ;
Irani, C ;
O'Neill, GM ;
Gordon, ND ;
Amrani, Y ;
Penn, RB ;
Panettieri, RA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (04) :465-474
[2]   NF-κB, Inflammation, and Metabolic Disease [J].
Baker, Rebecca G. ;
Hayden, Matthew S. ;
Ghosh, Sankar .
CELL METABOLISM, 2011, 13 (01) :11-22
[3]   Lung myofibroblasts as targets of salmeterol and fluticasone propionate:: inhibition of α-SMA and NF-κB [J].
Baouz, S ;
Giron-Michel, J ;
Azzarone, B ;
Giuliani, M ;
Cagnoni, F ;
Olsson, S ;
Testi, R ;
Gabbiani, G ;
Canonica, GW .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (11) :1473-1481
[4]   Regulation of the NF-κB-mediated transcription of inflammatory genes [J].
Bhatt, Dev ;
Ghosh, Sankar .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[5]   A mechanism converting psychosocial stress into mononuclear cell activation [J].
Bierhaus, A ;
Wolf, J ;
Andrassy, M ;
Rohleder, N ;
Humpert, PM ;
Petrov, D ;
Ferstl, R ;
von Eynatten, M ;
Wendt, T ;
Rudofsky, G ;
Joswig, M ;
Morcos, M ;
Schwaninger, M ;
McEwen, B ;
Kirschbaum, C ;
Nawroth, PP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1920-1925
[6]   Stress and the inflammatory response: A review of neurogenic inflammation [J].
Black, PH .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (06) :622-653
[7]   Epac: a new cAMP target and new avenues in cAMP research [J].
Bos, JL .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (09) :733-738
[8]   Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury [J].
Bosmann, Markus ;
Grailer, Jamison J. ;
Zhu, Ketong ;
Matthay, Michael A. ;
Sarma, J. Vidya ;
Zetoune, Firas S. ;
Ward, Peter A. .
FASEB JOURNAL, 2012, 26 (05) :2137-2144
[9]   Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals [J].
Bruzzone, Ariana ;
Sauliere, Aude ;
Finana, Frederic ;
Senard, Jean-Michel ;
Luethy, Isabel ;
Gales, Celine .
FASEB JOURNAL, 2014, 28 (03) :1342-1354
[10]   β2-adrenoceptor agonists: current and future direction [J].
Cazzola, Mario ;
Calzetta, Luigino ;
Matera, Maria Gabriella .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) :4-17